Literature DB >> 21130135

Expression of linear permutated variants from circular enterocin AS-48.

Manuel Montalbán-López1, Manuel Martínez-Bueno, Eva Valdivia, Mercedes Maqueda.   

Abstract

To confirm whether the head-to-tail circularization could be involved in the stability and activity of the circular bacteriocin AS-48, two permutated linear structural as-48A genes have been constructed by circular permutation. The absence of the leaderless linear AS(23/24) and AS(48/49) proteins in Escherichia coli, under all the conditions investigated, supports the idea that the circular backbone is important to stabilize their structure and also indicates the significance of a leader peptide. In fact, the approach taken in this study to generate linear permutated proteins fused to an appropriate partner was sufficient to prevent cellular proteolysis. In this case, the high expression levels found favour their intracellular accumulations as inclusion bodies, which after solubilization showed a propensity to aggregate, thus hindering the specific EK cleavage. This could explain the presence of active hybrid tagged proteins identified in this work. The conserved distribution of hydrophobic and hydrophilic surfaces in the hybrid proteins is responsible for the antibacterial activity. In addition, the opening of the AS-48 molecule between the residues G(23) W(24) connecting the α1/α2 helices, confers greater stability, suggesting that the sequence and/or the free amino acid in the polypeptide chain are critical aspects in the design of new variants.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130135     DOI: 10.1016/j.biochi.2010.11.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

Review 1.  AS-48 bacteriocin: close to perfection.

Authors:  Marina Sánchez-Hidalgo; Manuel Montalbán-López; Rubén Cebrián; Eva Valdivia; Manuel Martínez-Bueno; Mercedes Maqueda
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

Review 2.  Circular bacteriocins: biosynthesis and mode of action.

Authors:  Christina Gabrielsen; Dag A Brede; Ingolf F Nes; Dzung B Diep
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

3.  Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

Authors:  Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

4.  Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.

Authors:  Francisco R Fields; Katelyn E Carothers; Rashna D Balsara; Victoria A Ploplis; Francis J Castellino; Shaun W Lee
Journal:  J Antibiot (Tokyo)       Date:  2018-02-20       Impact factor: 2.649

5.  Genome-guided identification of novel head-to-tail cyclized antimicrobial peptides, exemplified by the discovery of pumilarin.

Authors:  Auke J van Heel; Manuel Montalban-Lopez; Quentin Oliveau; Oscar P Kuipers
Journal:  Microb Genom       Date:  2017-09-25

6.  Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.

Authors:  Jessica N Ross; Francisco R Fields; Veronica R Kalwajtys; Alejandro J Gonzalez; Samantha O'Connor; Angela Zhang; Thomas E Moran; Daniel E Hammers; Katelyn E Carothers; Shaun W Lee
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

Review 7.  The Cyclic Antibacterial Peptide Enterocin AS-48: Isolation, Mode of Action, and Possible Food Applications.

Authors:  María José Grande Burgos; Rubén Pérez Pulido; María Del Carmen López Aguayo; Antonio Gálvez; Rosario Lucas
Journal:  Int J Mol Sci       Date:  2014-12-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.